We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+21.94%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$34.9B
AUM Growth
+$6.68B
(+24%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
7.42%
Holding
3,971
New
955
Increased
1,167
Reduced
1,145
Closed
694
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Financials | 9.05% |
| 4 | Healthcare | 8.71% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vornado Realty Trust
VNO
$7.38B
| $1.01M | ﹤0.01% |
+27,167
| New | +$992K |
|
2002
PUT
Oneok
OKE
$54.5B
| $1.01M | ﹤0.01% |
26,400
-79,200
| -75% | -$2.66M |
|
2003
Jacobs Solutions
J
$17B
| $1.01M | ﹤0.01% |
+11,234
| New | +$952K |
|
2004
Minerva Neurosciences
NERV
$199M
| $1.01M | ﹤0.01% |
53,932
+28,948
| +116% | +$729K |
|
2005
PUT
BJs Wholesale Club
BJ
$12.3B
| $1M | ﹤0.01% |
26,900
-1,000
| -4% | -$40K |
|
2006
Molina Healthcare
MOH
$10.3B
| $1M | ﹤0.01% |
4,713
+1,353
| +40% | +$279K |
|
|
AGRX
2007
DELISTED
Agile Therapeutics
AGRX
| $1M | ﹤0.01% |
175
+86
| +97% | +$506K |
|
2008
Cerus
CERS
$474M
| $1M | ﹤0.01% |
144,523
-50,997
| -26% | -$334K |
|
2009
PUT
Steel Dynamics
STLD
$37.6B
| $999K | ﹤0.01% |
27,100
+17,100
| +171% | +$594K |
|
2010
PUT
Marathon Digital Holdings
MARA
$3.9B
| $996K | ﹤0.01% |
+95,400
| New | +$440K |
|
2011
PUT
Baidu
BIDU
$37.2B
| $995K | ﹤0.01% |
4,600
+900
| +24% | +$134K |
|
2012
Ryman Hospitality Properties
RHP
$7.63B
| $992K | ﹤0.01% |
+14,641
| New | +$785K |
|
2013
Hawaiian Electric Industries
HE
$2.14B
| $991K | ﹤0.01% |
28,016
-132,326
| -83% | -$4.68M |
|
2014
PUT
Nutanix
NTNX
$16.9B
| $991K | ﹤0.01% |
31,100
-3,600
| -10% | -$97.6K |
|
2015
CALL
Toll Brothers
TOL
$14.5B
| $991K | ﹤0.01% |
22,800
+12,800
| +128% | +$594K |
|
|
KZR
2016
DELISTED
Kezar Life Sciences
KZR
| $990K | ﹤0.01% |
18,970
-3,317
| -15% | -$185K |
|
2017
PUT
Oracle
ORCL
$423B
| $990K | ﹤0.01% |
15,300
-400
| -3% | -$23.8K |
|
|
VRAY
2018
DELISTED
ViewRay, Inc.
VRAY
| $990K | ﹤0.01% |
+259,222
| New | +$917K |
|
2019
CALL
First Solar
FSLR
$26.9B
| $989K | ﹤0.01% |
10,000
-1,500
| -13% | -$130K |
|
2020
CALL
QuidelOrtho
QDEL
$838M
| $988K | ﹤0.01% |
5,500
+4,500
| +450% | +$1M |
|
2021
Acacia Research
ACTG
$470M
| $987K | ﹤0.01% |
250,523
+104,273
| +71% | +$374K |
|
2022
CALL
HCA Healthcare
HCA
$89.5B
| $987K | ﹤0.01% |
+6,000
| New | +$877K |
|
2023
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $986K | ﹤0.01% |
55,826
-219,618
| -80% | -$3.86M |
|
2024
Sabra Healthcare REIT
SBRA
$5.37B
| $986K | ﹤0.01% |
+56,760
| New | +$906K |
|
|
2025
CALL
S&P Global
SPGI
$120B
| $986K | ﹤0.01% |
3,000
-3,200
| -52% | -$1.08M |
|
Similar funds
VAM
Two Sigma Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Two Sigma Investments held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
Two Sigma Investments deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- Two Sigma Investments's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- Two Sigma Investments added most to NVIDIA in Q4 2020, an estimated $257M increase.
- Two Sigma Investments's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- Two Sigma Investments fully exited Pfizer in Q4 2020, selling an estimated $252M.
- Two Sigma Investments's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- Two Sigma Investments opened 955 new positions and closed 694 in Q4 2020.
- Two Sigma Investments's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.